Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 253 to 257 of 257 entries
Sorted by: Best Match Show Resources per page
Impact of maternal hypertensive disorders of pregnancy on brain volumes at term-equivalent age in preterm infants: A voxel-based morphometry study.

Pregnancy hypertension

Ushida T, Kidokoro H, Nakamura N, Katsuki S, Imai K, Nakano-Kobayashi T, Moriyama Y, Sato Y, Hayakawa M, Natsume J, Kajiyama H, Kotani T.
PMID: 34139669
Pregnancy Hypertens. 2021 Aug;25:143-149. doi: 10.1016/j.preghy.2021.06.003. Epub 2021 Jun 09.

OBJECTIVES: Infants born to mothers with hypertensive disorders of pregnancy (HDP) reportedly have negative behavioral and neurodevelopmental outcomes. However, the effects of maternal HDP on infant brain growth have not been fully evaluated. We aimed to evaluate brain volumes...

Cite
Ushida T, Kidokoro H, Nakamura N, et al. Impact of maternal hypertensive disorders of pregnancy on brain volumes at term-equivalent age in preterm infants: A voxel-based morphometry study. Pregnancy Hypertens. 2021;25:143-149doi: 10.1016/j.preghy.2021.06.003.
Ushida, T., Kidokoro, H., Nakamura, N., Katsuki, S., Imai, K., Nakano-Kobayashi, T., Moriyama, Y., Sato, Y., Hayakawa, M., Natsume, J., Kajiyama, H., & Kotani, T. (2021). Impact of maternal hypertensive disorders of pregnancy on brain volumes at term-equivalent age in preterm infants: A voxel-based morphometry study. Pregnancy hypertension, 25143-149. https://doi.org/10.1016/j.preghy.2021.06.003
Ushida, Takafumi, et al. "Impact of maternal hypertensive disorders of pregnancy on brain volumes at term-equivalent age in preterm infants: A voxel-based morphometry study." Pregnancy hypertension vol. 25 (2021): 143-149. doi: https://doi.org/10.1016/j.preghy.2021.06.003
Ushida T, Kidokoro H, Nakamura N, Katsuki S, Imai K, Nakano-Kobayashi T, Moriyama Y, Sato Y, Hayakawa M, Natsume J, Kajiyama H, Kotani T. Impact of maternal hypertensive disorders of pregnancy on brain volumes at term-equivalent age in preterm infants: A voxel-based morphometry study. Pregnancy Hypertens. 2021 Aug;25:143-149. doi: 10.1016/j.preghy.2021.06.003. Epub 2021 Jun 09. PMID: 34139669.
Copy Download .nbib Format: NLM
Iron oxide nanoparticles exert inhibitory effects on N-Bis(2-hydroxypropyl)nitrosamine (DHPN)-induced lung tumorigenesis in rats.

Regulatory toxicology and pharmacology : RTP

Tada Y, Hojo M, Yuzawa K, Nagasawa A, Suzuki J, Inomata A, Moriyasu T, Nakae D.
PMID: 34742869
Regul Toxicol Pharmacol. 2021 Nov 04;128:105072. doi: 10.1016/j.yrtph.2021.105072. Epub 2021 Nov 04.

Iron oxide nanoparticles (magnetite) have been widely used in industry and medicine. However, the safety assessment of magnetite has not been fully completed. The present study was conducted to assess effects of magnetite on carcinogenic activity, using a medium-term...

Cite
Tada Y, Hojo M, Yuzawa K, et al. Iron oxide nanoparticles exert inhibitory effects on N-Bis(2-hydroxypropyl)nitrosamine (DHPN)-induced lung tumorigenesis in rats. Regul Toxicol Pharmacol. 2021;128:105072doi: 10.1016/j.yrtph.2021.105072.
Tada, Y., Hojo, M., Yuzawa, K., Nagasawa, A., Suzuki, J., Inomata, A., Moriyasu, T., & Nakae, D. (2021). Iron oxide nanoparticles exert inhibitory effects on N-Bis(2-hydroxypropyl)nitrosamine (DHPN)-induced lung tumorigenesis in rats. Regulatory toxicology and pharmacology : RTP, 128105072. https://doi.org/10.1016/j.yrtph.2021.105072
Tada, Yukie, et al. "Iron oxide nanoparticles exert inhibitory effects on N-Bis(2-hydroxypropyl)nitrosamine (DHPN)-induced lung tumorigenesis in rats." Regulatory toxicology and pharmacology : RTP vol. 128 (2021): 105072. doi: https://doi.org/10.1016/j.yrtph.2021.105072
Tada Y, Hojo M, Yuzawa K, Nagasawa A, Suzuki J, Inomata A, Moriyasu T, Nakae D. Iron oxide nanoparticles exert inhibitory effects on N-Bis(2-hydroxypropyl)nitrosamine (DHPN)-induced lung tumorigenesis in rats. Regul Toxicol Pharmacol. 2021 Nov 04;128:105072. doi: 10.1016/j.yrtph.2021.105072. Epub 2021 Nov 04. PMID: 34742869.
Copy Download .nbib Format: NLM
Positive Association between High Protein Food Intake Frequency and Physical Performance and Higher-Level Functional Capacity in Daily Life.

Nutrients

Kimura M, Moriyasu A, Makizako H.
PMID: 35010947
Nutrients. 2021 Dec 24;14(1). doi: 10.3390/nu14010072.

Nutritional factors, including low protein intake and poor dietary variety, affect age-associated impairment in physical performance resulting in physical frailty. This cross-sectional study investigated the association between intake frequency of major high protein foods and both physical performance and...

Cite
Kimura M, Moriyasu A, Makizako H. Positive Association between High Protein Food Intake Frequency and Physical Performance and Higher-Level Functional Capacity in Daily Life. Nutrients. 2021;14(1)doi: 10.3390/nu14010072.
Kimura, M., Moriyasu, A., & Makizako, H. (2021). Positive Association between High Protein Food Intake Frequency and Physical Performance and Higher-Level Functional Capacity in Daily Life. Nutrients, 14(1), . https://doi.org/10.3390/nu14010072
Kimura, Mika, et al. "Positive Association between High Protein Food Intake Frequency and Physical Performance and Higher-Level Functional Capacity in Daily Life." Nutrients vol. 14,1 (2021). doi: https://doi.org/10.3390/nu14010072
Kimura M, Moriyasu A, Makizako H. Positive Association between High Protein Food Intake Frequency and Physical Performance and Higher-Level Functional Capacity in Daily Life. Nutrients. 2021 Dec 24;14(1). doi: 10.3390/nu14010072. PMID: 35010947; PMCID: PMC8746446.
Copy Download .nbib Format: NLM
Association between glucose intolerance and chemotherapy-induced lung injury in patients with lung cancer and interstitial lung disease.

Cancer chemotherapy and pharmacology

Otani T, Yamaguchi K, Nakao S, Sakamoto S, Horimasu Y, Masuda T, Miyamoto S, Nakashima T, Iwamoto H, Fujitaka K, Hamada H, Hattori N.
PMID: 34350479
Cancer Chemother Pharmacol. 2021 Nov;88(5):857-865. doi: 10.1007/s00280-021-04341-y. Epub 2021 Aug 04.

PURPOSE: Cytotoxic chemotherapy-induced lung injury is a fatal complication in patients with lung cancer and interstitial lung disease (ILD). We aimed to evaluate the association between hyperglycemia and this form of lung injury in patients with lung cancer concomitant...

Cite
Otani T, Yamaguchi K, Nakao S, et al. Association between glucose intolerance and chemotherapy-induced lung injury in patients with lung cancer and interstitial lung disease. Cancer Chemother Pharmacol. 2021;88(5):857-865doi: 10.1007/s00280-021-04341-y.
Otani, T., Yamaguchi, K., Nakao, S., Sakamoto, S., Horimasu, Y., Masuda, T., Miyamoto, S., Nakashima, T., Iwamoto, H., Fujitaka, K., Hamada, H., & Hattori, N. (2021). Association between glucose intolerance and chemotherapy-induced lung injury in patients with lung cancer and interstitial lung disease. Cancer chemotherapy and pharmacology, 88(5), 857-865. https://doi.org/10.1007/s00280-021-04341-y
Otani, Toshihito, et al. "Association between glucose intolerance and chemotherapy-induced lung injury in patients with lung cancer and interstitial lung disease." Cancer chemotherapy and pharmacology vol. 88,5 (2021): 857-865. doi: https://doi.org/10.1007/s00280-021-04341-y
Otani T, Yamaguchi K, Nakao S, Sakamoto S, Horimasu Y, Masuda T, Miyamoto S, Nakashima T, Iwamoto H, Fujitaka K, Hamada H, Hattori N. Association between glucose intolerance and chemotherapy-induced lung injury in patients with lung cancer and interstitial lung disease. Cancer Chemother Pharmacol. 2021 Nov;88(5):857-865. doi: 10.1007/s00280-021-04341-y. Epub 2021 Aug 04. PMID: 34350479.
Copy Download .nbib Format: NLM
Accelerated decline in lung function in adults with a history of remitted childhood asthma.

The European respiratory journal

Miura S, Iwamoto H, Omori K, Yamaguchi K, Sakamoto S, Horimasu Y, Masuda T, Miyamoto S, Nakashima T, Fujitaka K, Hamada H, Yokoyama A, Hattori N.
PMID: 34588191
Eur Respir J. 2022 Jan 13;59(1). doi: 10.1183/13993003.00305-2021. Print 2022 Jan.

BACKGROUND: A significant number of children with asthma show remission in adulthood. Although these adults are often diagnosed with COPD in later life, the effect of clinically remitted childhood asthma on the decline in lung function during adulthood is...

Cite
Miura S, Iwamoto H, Omori K, et al. Accelerated decline in lung function in adults with a history of remitted childhood asthma. Eur Respir J. 2022;59(1)doi: 10.1183/13993003.00305-2021.
Miura, S., Iwamoto, H., Omori, K., Yamaguchi, K., Sakamoto, S., Horimasu, Y., Masuda, T., Miyamoto, S., Nakashima, T., Fujitaka, K., Hamada, H., Yokoyama, A., & Hattori, N. (2022). Accelerated decline in lung function in adults with a history of remitted childhood asthma. The European respiratory journal, 59(1), . https://doi.org/10.1183/13993003.00305-2021
Miura, Shinichiro, et al. "Accelerated decline in lung function in adults with a history of remitted childhood asthma." The European respiratory journal vol. 59,1 (2022). doi: https://doi.org/10.1183/13993003.00305-2021
Miura S, Iwamoto H, Omori K, Yamaguchi K, Sakamoto S, Horimasu Y, Masuda T, Miyamoto S, Nakashima T, Fujitaka K, Hamada H, Yokoyama A, Hattori N. Accelerated decline in lung function in adults with a history of remitted childhood asthma. Eur Respir J. 2022 Jan 13;59(1). doi: 10.1183/13993003.00305-2021. Print 2022 Jan. PMID: 34588191.
Copy Download .nbib Format: NLM
Showing 253 to 257 of 257 entries